163 related articles for article (PubMed ID: 33307325)
1. Obesity and visceral fat: Survival impact in high-grade endometrial cancer.
Donkers H; Fasmer KE; Mcgrane J; Pijnenborg JMA; Bekkers R; Haldorsen IS; Galaal K
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():425-432. PubMed ID: 33307325
[TBL] [Abstract][Full Text] [Related]
2. The role of sarcopenic obesity in high-grade endometrial cancer.
Donkers H; Fasmer KE; Mcgrane J; Pijnenborg JMA; Bekkers R; Haldorsen IS; Galaal K
Int J Gynaecol Obstet; 2021 Aug; 154(2):248-255. PubMed ID: 33445216
[TBL] [Abstract][Full Text] [Related]
3. Impact of body mass index and fat distribution on sex steroid levels in endometrial carcinoma: a retrospective study.
van Weelden WJ; Fasmer KE; Tangen IL; IntHout J; Abbink K; van Herwaarden AE; Krakstad C; Massuger LFAG; Haldorsen IS; Pijnenborg JMA
BMC Cancer; 2019 Jun; 19(1):547. PubMed ID: 31174495
[TBL] [Abstract][Full Text] [Related]
4. High visceral fat percentage is associated with poor outcome in endometrial cancer.
Mauland KK; Eng Ø; Ytre-Hauge S; Tangen IL; Berg A; Salvesen HB; Salvesen ØO; Krakstad C; Trovik J; Hoivik EA; Werner HMJ; Mellgren G; Haldorsen IS
Oncotarget; 2017 Dec; 8(62):105184-105195. PubMed ID: 29285243
[TBL] [Abstract][Full Text] [Related]
5. Using simple radiologic measurements to anticipate surgical challenge in endometrial cancer: a prospective study.
Harrison RF; Mcnamara JE; Beaumont CB; Sadowski EA; Chappell RJ; Shahzad MM; Spencer RJ; Al-Niaimi AN; Barroilhet LM; Rose SL; Kushner DM
Int J Gynecol Cancer; 2019 Jan; 29(1):102-107. PubMed ID: 30640690
[TBL] [Abstract][Full Text] [Related]
6. Visceral Adipose Tissue Percentage Compared to Body Mass Index as Better Indicator of Surgical Outcomes in Women With Obesity and Endometrial Cancer.
Yoshida K; Kondo E; Ishida M; Ichikawa Y; Watashige N; Okumura A; Matsumoto T; Okamoto K; Maki S; Kubo-Kaneda M; Nii M; Ikeda T
J Minim Invasive Gynecol; 2024 May; 31(5):445-452. PubMed ID: 38417674
[TBL] [Abstract][Full Text] [Related]
7. The role of fat distribution and inflammation in the origin of endometrial cancer, study protocol of the ENDOCRINE study.
van den Bosch AAS; Pijnenborg JMA; Romano A; Haldorsen IS; Werner HMJ
PLoS One; 2022; 17(10):e0276516. PubMed ID: 36301824
[TBL] [Abstract][Full Text] [Related]
8. Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer?
Celik E; Kizildag Yirgin I; Goksever Celik H; Engin G; Sozen H; Ak N; Saip P; Onder S; Topuz S; Salihoglu MY
J Obstet Gynaecol Res; 2021 Feb; 47(2):560-569. PubMed ID: 33197987
[TBL] [Abstract][Full Text] [Related]
9. Visceral-to-subcutaneous fat ratio is a possible prognostic factor for type 1 endometrial cancer.
Wada M; Yamaguchi K; Yamakage H; Inoue T; Kusakabe T; Abiko K; Takakura K; Konishi I; Satoh-Asahara N
Int J Clin Oncol; 2022 Feb; 27(2):434-440. PubMed ID: 34716844
[TBL] [Abstract][Full Text] [Related]
10. The association between diabetes, comorbidities, body mass index and all-cause and cause-specific mortality among women with endometrial cancer.
Nagle CM; Crosbie EJ; Brand A; Obermair A; Oehler MK; Quinn M; Leung Y; Spurdle AB; Webb PM;
Gynecol Oncol; 2018 Jul; 150(1):99-105. PubMed ID: 29706522
[TBL] [Abstract][Full Text] [Related]
11. Association between visceral fat, IL-8 and endometrial cancer.
Ciortea R; Mihu D; Mihu CM
Anticancer Res; 2014 Jan; 34(1):379-83. PubMed ID: 24403491
[TBL] [Abstract][Full Text] [Related]
12. Obesity, Visceral Fat, and Hypertension-Related Complications.
Haberka M; Stolarz-Skrzypek K; Biedroń M; Szóstak-Janiak K; Partyka M; Olszanecka-Glinianowicz M; Gąsior Z
Metab Syndr Relat Disord; 2018 Dec; 16(10):521-529. PubMed ID: 30183499
[No Abstract] [Full Text] [Related]
13. Visceral fat percentage for prediction of outcome in uterine cervical cancer.
Eide AJ; Halle MK; Lura N; Fasmer KE; Wagner-Larsen K; Forsse D; Bertelsen BI; Salvesen Ø; Krakstad C; Haldorsen IS
Gynecol Oncol; 2023 Sep; 176():62-68. PubMed ID: 37453220
[TBL] [Abstract][Full Text] [Related]
14. Abdominal visceral fat accumulation measured by computed tomography associated with an increased risk of gallstone disease.
Sekine K; Nagata N; Sakamoto K; Arai T; Shimbo T; Shinozaki M; Okubo H; Watanabe K; Imbe K; Mikami S; Nozaki Y; Sakurai T; Yokoi C; Kojima Y; Kobayakawa M; Yanase M; Akiyama J; Noda M; Uemura N
J Gastroenterol Hepatol; 2015 Aug; 30(8):1325-31. PubMed ID: 25869941
[TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome--related endometrial carcinomas show a high frequency of nonendometrioid types and of high FIGO grade endometrioid types.
Carcangiu ML; Radice P; Casalini P; Bertario L; Merola M; Sala P
Int J Surg Pathol; 2010 Feb; 18(1):21-6. PubMed ID: 19443869
[TBL] [Abstract][Full Text] [Related]
16. Higher visceral fat area/subcutaneous fat area ratio measured by computed tomography is associated with recurrence and poor survival in patients with mid and low rectal cancers.
Lee KH; Kang BK; Ahn BK
Int J Colorectal Dis; 2018 Sep; 33(9):1303-1307. PubMed ID: 29713823
[TBL] [Abstract][Full Text] [Related]
17. Not all fat is equal: differential gene expression and potential therapeutic targets in subcutaneous adipose, visceral adipose, and endometrium of obese women with and without endometrial cancer.
Modesitt SC; Hsu JY; Chowbina SR; Lawrence RT; Hoehn KL
Int J Gynecol Cancer; 2012 Jun; 22(5):732-41. PubMed ID: 22635025
[TBL] [Abstract][Full Text] [Related]
18. Predictors for cecal insertion time: the impact of abdominal visceral fat measured by computed tomography.
Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Noda M; Uemura N
Dis Colon Rectum; 2014 Oct; 57(10):1213-9. PubMed ID: 25203379
[TBL] [Abstract][Full Text] [Related]
19. Clear cell renal cell carcinoma: the value of sex-specific abdominal visceral fat measured on CT for prediction of Fuhrman nuclear grade.
Hu Z; Wu J; Lai S; Xu Y; Zhan J; Li R; Liu X; Wang N; Wei X; Jiang X; Yang R
Eur Radiol; 2020 Jul; 30(7):3977-3986. PubMed ID: 32144457
[TBL] [Abstract][Full Text] [Related]
20. [Influence of obesity on clinicopathological characteristics in patients with clinically localized prostate cancer].
Qu YY; Dai B; Chang K; Kong YY; Gu CY; Zhang GM; Wan FN; Wang HK; Zhang HL; Zhu Y; Ye DW
Zhonghua Wai Ke Za Zhi; 2013 Dec; 51(12):1089-93. PubMed ID: 24499718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
